CAG
XLRN

Crestwood Advisors Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Crestwood Advisors Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-194
Closed -$6K – 471
2017
Q1 		$6K Buy
+194
New +$6K ﹤0.01% 469